Fredericton, New Brunswick-based Emergence client, SomaDetect has announced the launch of its pilot program – two months ahead of schedule. Congratulations!
Since July 19, SomaDetect has installed its sensors on two robotic milking systems. This is a significant milestone in the product development process for SomaDetect, and helps demonstrate that the sensor can run unsupervised without intervention, and provide accurate data.
“Feedback gained from the pilot project will be used to further develop and commercialize our technology,” SomaDetect CEO, Bethany Deshpande, told us.
Entrevestor, meanwhile, reports that SomaDetect been validating the international demand for its product. Entrevestor reports that SomaDetect recently signed letters of intent with three-quarters of the 80 farmers it met with during a recent four-day road trip to Vermont. The trip to Vermont was used to assess the market for SomaDetect’s product, which can quickly detect diseases in cows.
SomaDetect helps dairy farmers check the health of their herd quickly, accurately and precisely while testing the quality of their milk.
The venture’s patented technology sends a laser beam through the milk as each cow is milked, instantly recording the fat content and somatic cell count, both of which indicate the presence of the disease mastitis and the quality of the milk. The farmer has the data instantly for each cow twice a day.
By catching the disease early enough, SomaDetect can prevent mastitis disease from moving through the herd, save the lives of some cows, and reduce the amount of antibiotics used by dairy farmers. The product also captures each farm’s data in the cloud, which can produce reports in real time for the farmer.
Soma detect believes that the trip validated their belief that SomaDetect can find a market beyond Atlantic Canada. Over the four days, Deshpande met with 80 farmers and 60 of them signed letters of intent to buy the product once it’s on the market.
SomaDetect is looking to Vermont and Maine to be beachhead states for the company’s advance into the U.S. market.